175 related articles for article (PubMed ID: 2920475)
1. Association of near-diploid DNA content and N-myc amplification in neuroblastomas.
Dominici C; Negroni A; Romeo A; Castello MA; Clerico A; Scopinaro M; Mauro F; Raschellà G
Clin Exp Metastasis; 1989; 7(2):201-11. PubMed ID: 2920475
[TBL] [Abstract][Full Text] [Related]
2. Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma.
Bourhis J; De Vathaire F; Wilson GD; Hartmann O; Terrier-Lacombe MJ; Boccon-Gibod L; McNally NJ; Lemerle J; Riou G; Bénard J
Cancer Res; 1991 Jan; 51(1):33-6. PubMed ID: 1988094
[TBL] [Abstract][Full Text] [Related]
3. N-myc genomic content and DNA ploidy in stage IVS neuroblastoma.
Bourhis J; Dominici C; McDowell H; Raschella G; Wilson G; Castello MA; Plouvier E; Lemerle J; Riou G; Bénard J
J Clin Oncol; 1991 Aug; 9(8):1371-5. PubMed ID: 2072140
[TBL] [Abstract][Full Text] [Related]
4. Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastoma.
Cohn SL; Rademaker AW; Salwen HR; Franklin WA; Gonzales-Crussi F; Rosen ST; Bauer KD
Am J Pathol; 1990 May; 136(5):1043-52. PubMed ID: 2349963
[TBL] [Abstract][Full Text] [Related]
5. Correlation between the number of segmental chromosome aberrations and the age at diagnosis of diploid neuroblastomas without MYCN amplification.
Souzaki R; Tajiri T; Teshiba R; Kinoshita Y; Yosue R; Kohashi K; Oda Y; Taguchi T
J Pediatr Surg; 2011 Dec; 46(12):2228-32. PubMed ID: 22152855
[TBL] [Abstract][Full Text] [Related]
6. Combined determination of N-myc oncogene amplification and DNA ploidy in neuroblastoma. Complementary prognostic indicators.
Muraji T; Okamoto E; Fujimoto J; Suita S; Nakagawara A
Cancer; 1993 Nov; 72(9):2763-8. PubMed ID: 8402501
[TBL] [Abstract][Full Text] [Related]
7. A comparative analysis of nuclear DNA content and N-myc gene amplification in neuroblastoma.
Taylor SR; Locker J
Cancer; 1990 Mar; 65(6):1360-6. PubMed ID: 2306684
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric and molecular analysis of proliferative activity and DNA content in neuroblastoma: presence of stationary cells in S-phase.
Dominici C; Negroni A; Romeo A; McDowell H; Padula A; Pucci S; Cappelli C; Castello MA; Raschellà G
Anticancer Res; 1992; 12(1):59-63. PubMed ID: 1567182
[TBL] [Abstract][Full Text] [Related]
9. Similar chromosomal patterns and lack of N-myc gene amplification in localized and IV-S stage neuroblastomas in infants.
Hayashi Y; Inaba T; Hanada R; Yamada M; Nakagome Y; Yamamoto K
Med Pediatr Oncol; 1989; 17(2):111-5. PubMed ID: 2704332
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study.
Look AT; Hayes FA; Shuster JJ; Douglass EC; Castleberry RP; Bowman LC; Smith EI; Brodeur GM
J Clin Oncol; 1991 Apr; 9(4):581-91. PubMed ID: 2066755
[TBL] [Abstract][Full Text] [Related]
11. Neuroblastoma--clinical applications of molecular parameters.
Brodeur GM
Brain Pathol; 1990 Sep; 1(1):47-54. PubMed ID: 1669693
[TBL] [Abstract][Full Text] [Related]
12. Chromosome abnormalities, cellular DNA content, oncogene amplification and growth pattern in agar culture of human neuroblastomas.
Carlsen NL; Mortensen BT; Andersson PK; Larsen JK; Nielsen OH; Tommerup N
Anticancer Res; 1991; 11(1):353-8. PubMed ID: 2018371
[TBL] [Abstract][Full Text] [Related]
13. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas.
Seeger RC; Brodeur GM; Sather H; Dalton A; Siegel SE; Wong KY; Hammond D
N Engl J Med; 1985 Oct; 313(18):1111-6. PubMed ID: 4047115
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis of clinical heterogeneity in neuroblastoma.
Brodeur GM; Nakagawara A
Am J Pediatr Hematol Oncol; 1992 May; 14(2):111-6. PubMed ID: 1356315
[TBL] [Abstract][Full Text] [Related]
15. Correlative patterns between cellular DNA content, N-myc oncogene amplification, and karyotypic abnormalities in human neuroblastomas. A preliminary report.
Shannon BT; Qualman SJ; Jacobs D
Ann N Y Acad Sci; 1993 Mar; 677():450-3. PubMed ID: 8494240
[No Abstract] [Full Text] [Related]
16. myc gene amplification and expression in primary human neuroblastoma.
Slavc I; Ellenbogen R; Jung WH; Vawter GF; Kretschmar C; Grier H; Korf BR
Cancer Res; 1990 Mar; 50(5):1459-63. PubMed ID: 2302711
[TBL] [Abstract][Full Text] [Related]
17. Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis.
Shimada H; Stram DO; Chatten J; Joshi VV; Hachitanda Y; Brodeur GM; Lukens JN; Matthay KK; Seeger RC
J Natl Cancer Inst; 1995 Oct; 87(19):1470-6. PubMed ID: 7674334
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1.
Hayashi Y; Kanda N; Inaba T; Hanada R; Nagahara N; Muchi H; Yamamoto K
Cancer; 1989 Jan; 63(1):126-32. PubMed ID: 2910410
[TBL] [Abstract][Full Text] [Related]
19. Unfavorable DNA ploidy and Ha-ras p21 findings in neuroblastomas detected through mass screening.
Kusafuka T; Nagahara N; Oue T; Imura K; Nakamura T; Kobayashi Y; Komoto Y; Fukuzawa M; Okada A; Nakayama M
Cancer; 1995 Aug; 76(4):695-9. PubMed ID: 8625168
[TBL] [Abstract][Full Text] [Related]
20. N-myc amplification in neuroblastomas: histopathological, DNA ploidy, and clinical variables.
Oppedal BR; Oien O; Jahnsen T; Brandtzaeg P
J Clin Pathol; 1989 Nov; 42(11):1148-52. PubMed ID: 2584426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
